100 related articles for article (PubMed ID: 21382417)
1. Oct4-negative multipotent adult progenitor cells and mesenchymal stem cells as regulators of T-cell alloreactivity in mice.
Luyckx A; De Somer L; Jacobs S; Rutgeerts O; Lenaerts C; Roobrouck VD; Verfaillie CM; Waer M; Van Gool SW; Billiau AD
Immunol Lett; 2011 Jun; 137(1-2):78-81. PubMed ID: 21382417
[TBL] [Abstract][Full Text] [Related]
2. Clinical scale expanded adult pluripotent stem cells prevent graft-versus-host disease.
Kovacsovics-Bankowski M; Streeter PR; Mauch KA; Frey MR; Raber A; van't Hof W; Deans R; Maziarz RT
Cell Immunol; 2009; 255(1-2):55-60. PubMed ID: 19022422
[TBL] [Abstract][Full Text] [Related]
3. Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease.
Yañez R; Lamana ML; García-Castro J; Colmenero I; Ramírez M; Bueren JA
Stem Cells; 2006 Nov; 24(11):2582-91. PubMed ID: 16873762
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow-derived mesenchymal stem cells decrease acute graft-versus-host disease after allogeneic hematopoietic stem cells transplantation.
Tian Y; Deng YB; Huang YJ; Wang Y
Immunol Invest; 2008; 37(1):29-42. PubMed ID: 18214798
[TBL] [Abstract][Full Text] [Related]
5. The immunosuppressive effect of embryonic stem cells and mesenchymal stem cells on both primary and secondary alloimmune responses.
Han KH; Kang HG; Gil HJ; Lee EM; Ahn C; Yang J
Transpl Immunol; 2010 Jul; 23(3):141-6. PubMed ID: 20430098
[TBL] [Abstract][Full Text] [Related]
6. Multipotent Adult Progenitor Cells Suppress T Cell Activation in
Carty F; Corbett JM; Cunha JPMCM; Reading JL; Tree TIM; Ting AE; Stubblefield SR; English K
Front Immunol; 2018; 9():645. PubMed ID: 29740426
[TBL] [Abstract][Full Text] [Related]
7. Immunosuppressive properties of cloned bone marrow mesenchymal stem cells.
Xu G; Zhang L; Ren G; Yuan Z; Zhang Y; Zhao RC; Shi Y
Cell Res; 2007 Mar; 17(3):240-8. PubMed ID: 17325691
[TBL] [Abstract][Full Text] [Related]
8. Human multipotent adult progenitor cells are nonimmunogenic and exert potent immunomodulatory effects on alloreactive T-cell responses.
Jacobs SA; Pinxteren J; Roobrouck VD; Luyckx A; van't Hof W; Deans R; Verfaillie CM; Waer M; Billiau AD; Van Gool SW
Cell Transplant; 2013; 22(10):1915-28. PubMed ID: 23031260
[TBL] [Abstract][Full Text] [Related]
9. Proliferation-based T-cell selection for immunotherapy and graft-versus-host-disease prophylaxis in the context of bone marrow transplantation.
Pachnio A; Dietrich S; Klapper W; Humpe A; Schwake M; Sedlacek R; Gramatzki M; Beck C
Bone Marrow Transplant; 2006 Jul; 38(2):157-67. PubMed ID: 16820783
[TBL] [Abstract][Full Text] [Related]
10. Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis.
Zheng ZH; Li XY; Ding J; Jia JF; Zhu P
Rheumatology (Oxford); 2008 Jan; 47(1):22-30. PubMed ID: 18077486
[TBL] [Abstract][Full Text] [Related]
11. Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation.
Maitra B; Szekely E; Gjini K; Laughlin MJ; Dennis J; Haynesworth SE; Koç ON
Bone Marrow Transplant; 2004 Mar; 33(6):597-604. PubMed ID: 14716336
[TBL] [Abstract][Full Text] [Related]
12. The immunosuppressive effects of human bone marrow-derived mesenchymal stem cells target T cell proliferation but not its effector function.
Ramasamy R; Tong CK; Seow HF; Vidyadaran S; Dazzi F
Cell Immunol; 2008 Feb; 251(2):131-6. PubMed ID: 18502411
[TBL] [Abstract][Full Text] [Related]
13. Transplanted mesenchymal stem cells can inhibit the three developmental stages of murine acute graft-versus-host disease.
Li H; Guo Z; Zhu H; Li XS; Jiang X; Yao H; Wang X; Liao L; Liu Y; Wu Y; Zhang Y; Mao N
In Vivo; 2010; 24(5):659-66. PubMed ID: 20952730
[TBL] [Abstract][Full Text] [Related]
14. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
15. Immunosuppressive effects of mesenchymal stem cells: involvement of HLA-G.
Nasef A; Mathieu N; Chapel A; Frick J; François S; Mazurier C; Boutarfa A; Bouchet S; Gorin NC; Thierry D; Fouillard L
Transplantation; 2007 Jul; 84(2):231-7. PubMed ID: 17667815
[TBL] [Abstract][Full Text] [Related]
16. Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a regulatory/suppressive phenotype.
Maccario R; Podestà M; Moretta A; Cometa A; Comoli P; Montagna D; Daudt L; Ibatici A; Piaggio G; Pozzi S; Frassoni F; Locatelli F
Haematologica; 2005 Apr; 90(4):516-25. PubMed ID: 15820948
[TBL] [Abstract][Full Text] [Related]
17. Immunomodulatory effects of mesenchymal stem cells involved in favoring type 2 T cell subsets.
Lu X; Liu T; Gu L; Huang C; Zhu H; Meng W; Xi Y; Li S; Liu Y
Transpl Immunol; 2009 Dec; 22(1-2):55-61. PubMed ID: 19695330
[TBL] [Abstract][Full Text] [Related]
18. Immunomodulation by mesenchymal stem cells and clinical experience.
Le Blanc K; Ringdén O
J Intern Med; 2007 Nov; 262(5):509-25. PubMed ID: 17949362
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal stem cells alter migratory property of T and dendritic cells to delay the development of murine lethal acute graft-versus-host disease.
Li H; Guo Z; Jiang X; Zhu H; Li X; Mao N
Stem Cells; 2008 Oct; 26(10):2531-41. PubMed ID: 18635870
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppression by mesenchymal stromal cells: from culture to clinic.
Jones BJ; McTaggart SJ
Exp Hematol; 2008 Jun; 36(6):733-41. PubMed ID: 18474304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
